CardioExchange Archive

February 24th, 2014

Selections from Richard Lehman’s Literature Review: February 24th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include radiofrequency ablation vs. antiarrhythmic drugs as first-line treatment of paroxysmal AF, Symplicity HTN-1 and Symplicity HTN-3, and more.

---

February 18th, 2014

Trial Offers Little Support for Early Use of Radiofrequency Ablation in Atrial Fibrillation

Larry Husten, PHD

A new trial offers little support for early use of radiofrequency ablation (RFA) to treat atrial fibrillation (AF). Current guidelines state that RFA may be indicated in patients with symptomatic paroxysmal AF after antiarrhythmic drug therapy has failed. Although earlier hopes have been dashed that RFA would prove to be a cure for AF, some experts […]

---

October 29th, 2012

Selections from Richard Lehman’s Literature Review: October 29th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include CV risk factors and peripheral artery disease in men, radiofrequency ablation in paroxysmal AF, CPR duration and survival after in-hospital cardiac arrest, an everolimus-eluting stent vs. a bare-metal stent in STEMI, job strain and CHD, and more.

---

October 24th, 2012

Atrial Fibrillation: Radiofrequency Catheter Ablation and Antiarrhythmic Drug Therapy Compared

Larry Husten, PHD

A trial comparing radiofrequency catheter ablation (RFA) to antiarrhythmic drug therapy (AAD) as initial therapy for paroxysmal atrial fibrillation (AF) found no difference in the overall burden of AF between the groups. But the trial also turned up evidence supporting the use of RFA as an initial treatment strategy in some patients. In a paper published in […]

---